Pelvic varices

Summary

Pelvic varices (MONDO:0004869) is a disease and 3 clinical trials. Top therapeutic interventions include diosmin, ibuprofen, and hesperidin. A subtype of varicose disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	pelvic varices
Mondo ID	MONDO:0004869
DOID	DOID:9742
ICD-10-CM	I86.2
ICD-11	1717989511
SNOMED CT	17406005
UMLS	C0155795
MedGen	510082
Anatomy (UBERON)	UBERON:0002355
Is cancer (heuristic)	no

Also known as: pelvic region of trunk varicose disease · varicose disease of pelvic region of trunk

Disease family

This is a subtype of varicose disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › vascular disorder › vein disorder › varicose disease › pelvic varices

Related subtypes (2): esophageal varices, mesenteric varices

Subtypes (3): varicocele, hemorrhoid, vulval varices

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	2
PHASE4	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT04358497	PHASE4	UNKNOWN	Endovascular Versus Medical Treatment for the Pelvic Congestion Syndrome
NCT06124664	Not specified	RECRUITING	Study of Venous Outflow From the Lower Limbs in Patients With Pelvic Varicosities
NCT06168058	Not specified	RECRUITING	Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices

Drugs tested across these trials (top 30)

Molecule	Max phase	Trials referencing
DIOSMIN	4	1
IBUPROFEN	4	1
HESPERIDIN	3	1
CHEMBL3039392	0	1